|

Mesothelioma Tests Focus on Prediction and Prevention

12175645_breathing tube

A California mesothelioma doctor believes it may eventually be possible to predict who is likely to get malignant mesothelioma and even keep it from developing.

Only about 15 percent of people exposed to asbestos will go on to develop mesothelioma or lung cancer, but right now they have no way of knowing who they are.  Now scientists at UCLA and other mesothelioma treatment centers around the country, in conjunction with surgical oncologist Dr. Robert Cameron and the Pacific, Heart, Lung & Blood Institute (PHLBI), are gearing up to develop tests that could identify those at highest risk for asbestos-related malignancies.  The teams will also test methods of preventing mesothelioma or for finding it in its earliest stage.

Dr. Cameron and the research team at California’s PHLBI have already had some success with breath testing in lung cancer patients.  Now the team plans to expand the testing to patients exposed to asbestos and at risk for mesothelioma.  The test involves analysis of volatile hydrocarbons exhaled into a tube and collected on a filter.

Successfully identifying which asbestos-exposed individuals are most likely to get mesothelioma opens the door for testing whether a COX-2 inhibitor (such as Celebrex) could keep the cancer from developing in the first place. Earlier this year, researchers at the University of Hawaii reported that mesothelioma is the result of chronic inflammation at the cellular level.  COX-2 inhibitors have been shown to help prevent some types of cancer by blocking inflammation.  UCLA and PHLBI researchers will partner with Labor Unions to test the effectiveness of COX-2 inhibitors on high risk asbestos-exposed workers.

Because early detection is critical to survival with mesothelioma, the research teams will also be studying the use of protein profiles to find the cancer even before symptoms develop.  Indentifying which proteins are produced by mesothelioma cells can help scientists form a mesothelioma ‘fingerprint’.  The project will involve collecting blood and urine from mesothelioma patients in all stages of the disease as well as from asbestos-exposed individuals and healthy volunteers.  The findings could lead to a simple blood test to identify the mesothelioma ‘fingerprint’ at an early stage while there are more options for effective treatment.

Sources:

PHLBI Medical Research Overview, Pacific, Heart, Lung & Blood Institute

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…